Biohaven Ltd. ( BHVN ) is a clinical-stage biopharmaceutical company with a broad pipeline focused on neuroscience, immunology, muscle and metabolism, and oncology. Their Phase 2 depression trial for Opakalim (BHV-7000) reported that their candidate failed to meet its primary endpoint. As a result, BHVN discontinued its psychiatric researchMy name is Myriam Hernandez Alvarez. I received the Electronics and Telecommunication Engineering degree from the Escuela Politecnica Nacional, Quito, Ecuador, the M.Sc. ...